Search for: "Janssen v. Janssen"
Results 341 - 360
of 385
Sorted by Relevance
|
Sort by Date
10 May 2020, 4:28 pm
Breach- sanction: action as offered by publication 09597-19 Bremner v The Scotsman, 1 Accuracy (2019), Breach- sanction: action as offered by publication09539-19 A Woman v Hull Daily Mail, 2 Privacy (2019), 6 Children (2019), 9 Reporting of crime (2019), Breach- sanction: publication of adjudication 09155-19 Brown v thesundaytimes.co.uk, 1 Accuracy (2019), No breach- after investigation 07966-19 Water UK v The Times,1 Accuracy (2019), Breach- sanction:… [read post]
12 Dec 2023, 5:00 am
The disclosure of the records, and subsequent analysis thereof led by the HJI have revealed that not only was South Africa charged more for COVID-19 vaccines than countries in the Global North, but also that the terms and conditions that the state had to agree to were overwhelmingly one-sided, favouring multinational pharmaceutical companies (including Janssen Pharmaceuticals, which produces the J&J vaccine, as well as with Pfizer, and the Serum Institute of India) and… [read post]
19 Jan 2015, 6:45 am
The plaintiff applied for a job as an area business specialist with Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals. [read post]
4 May 2017, 11:12 pm
A recent example of the court’s flexibility can be seen in Arnold J’s recent judgment in FAPL v BT [2017] EWHC 480 Ch. [read post]
19 Apr 2017, 2:21 am
However, whichever way the learned judges decide, it seems certain that “in accordance with the principles set out in Eli Lilly v Actavis” will soon be a recurring phrase for UK patent litigators when setting out their arguments on claim construction. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog)… [read post]
21 Apr 2017, 6:59 am
Penny sketched out the facts of the FKB v AbbVie litigation in the UK and the finding of Henry Carr J that it was appropriate to grant declarations that a dosage regime for a biosimilar product would have been anticipated or obvious at the priority date of a granted patent in the circumstances. [read post]
7 Mar 2008, 5:47 am
Ranbaxy Laboratories Ltd. v. [read post]
23 Mar 2011, 12:18 pm
Janssen, L.P., slip op. [read post]
4 Oct 2023, 10:00 pm
The Plaintiffs argued the unconstitutionality of the Medicare Negotiation Program under the Fifth Amendment by relying on Michigan Bell v. [read post]
21 Feb 2021, 4:07 pm
Published in Internet Policy Review (18 December 2020), 9(4), pp 1 – 25; https://doi.org/10.14763/2020.4.1536 , Heleen Janssen, University of Cambridge – Computer Laboratory, Jennifer C [read post]
6 Jul 2007, 4:29 am
See Larkin v. [read post]
3 Sep 2015, 6:36 am
Health Ctr. v. [read post]
2 Jun 2011, 12:46 pm
Nail v. [read post]
27 Mar 2015, 2:02 pm
Janssen Pharms., Inc., No. 239 EDA 2014, 2015 Pa. [read post]
24 Feb 2011, 1:49 pm
Janssen Pharmaceutica, Inc., 2006 WL 3665417, at *4 n.2 (S.D. [read post]
3 Jul 2017, 5:37 am
The Huawei v. [read post]
3 Jul 2017, 5:37 am
The Huawei v. [read post]
18 Apr 2012, 1:29 pm
Janssen Pharmaceuticals, Inc., 951 N.E.2d 1238 (Ill. [read post]
31 Dec 2015, 5:12 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., ___ F.3d ___, 2015 WL 8538119 (6th Cir. [read post]
